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1. Introduction
Predominantly inverse associations of height with all-
cause mortality have been found in a large number of
studies in developed countries (Davey Smith et al., 2000;
Engeland et al., 2003; Jousilahti et al., 2000; Koch, 2011;
Song et al., 2003; Song and Sung, 2008). This appears to be
driven by inverse associations of height with cardiovas-
cular disease (CVD) and respiratory disease mortality
(Cook et al., 1994; Gunnell et al., 2003; Lawlor et al., 2004;
Lee et al., 2009; Paajanen et al., 2010), and partly
counteracted by positive associations with many forms
of non-smoking related cancers (Batty et al., 2010; Green
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A B S T R A C T
Height is associated with mortality from many diseases, but it remains unclear whether
the association is causal or due to confounding by social factors, genetic pleiotropy,1 or
existing ill-health. The authors investigated whether the association of height with
mortality is causal by using a son’s height as an instrumental variable (IV) for parents’
height among the parents of a cohort of 1,036,963 Swedish men born between 1951 and
1980 who had their height measured at military conscription, aged around 18, between
1969 and 2001. In a two-sample IV analysis adjusting for son’s age at examination and
secular trends in height, as well as parental age, and socioeconomic position, the hazard
ratio (HR) for all-cause paternal mortality per standard deviation (SD, 6.49 cm) of height
was 0.96 (95% conﬁdence interval (CI): 0.95, 0.96). The results of IV analyses of mortality
from all causes, cardiovascular disease (CVD), respiratory disease, cancer, external causes
and suicide were comparable to those obtained using son’s height as a simple proxy for
own height and to conventional analyses of own height in the present data and elsewhere,
suggesting that such conventional analyses are not substantially confounded by existing
ill-health.
 2012 Elsevier B.V. 
Abbreviations: IV, instrumental variable; HR, hazard ratio; SD, stan-
 deviation; CI, conﬁdence interval; CVD, cardiovascular disease; BMI,
y mass index; SEP, socioeconomic position; CHD, coronary heart
ase.
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underlying these associations, however, are unclear. They
might be explained by residual confounding, for example
by socioeconomic position (Batty et al., 2006; Davey Smith
et al., 2000; Gunnell, 2002; Leon et al., 1995), by genetic
variants with pleiotropic effects (Silventoinen et al., 2003),
or confounding due to existing but undiagnosed illness
(sometimes also referred to as reverse causality). Beyond
confounding, a range of possible biological mechanisms
have been proposed. For example, the greater lung capacity
of taller people might be protective against respiratory
disease (Batty et al., 2006; Davey Smith et al., 2000), while
the increased risk of most cancers in taller people might be
due to the increased number of cells available to become
cancerous (Albanes and Winick, 1988). It is important to
establish whether an association is causal before exploring
the plausibility of different biological mechanisms which
could provide insights into the prevention of disease.
Various approaches have been taken to quantify, or to
adjust for, the inﬂuence of confounding on these associa-
tions. Studies of monozygotic and dizygotic twins (Lundq-
vist et al., 2007; Silventoinen et al., 2003, 2006) can begin
to establish whether genetic or shared environmental
characteristics explain the associations. The study of
socially homogeneous groups (McCarron et al., 2002;
Murray, 1997; Okasha et al., 2000) has reduced the
inﬂuence of social confounding, at the cost of a loss of
generality. To avoid confounding due to ill-health and the
resultant shrinkage, several studies have used a subject’s
maximum height, or excluded deaths occurring in the ﬁrst
few years after measurement (Batty et al., 2010; Leon et al.,
1995; McCarron et al., 2002). These studies suggest that all
of the listed sources of confounding may apply for some
causes of mortality in some circumstances, but adjustment
for confounders has always been imperfect, and many
studies have been restricted to particular causes of
mortality, in limited study samples.
Here, we take another approach to adjustment for
confounding, using offspring height as an instrumental
variable (IV) for assessing the causal effect of own height
on all-cause and cause-speciﬁc mortality. The adult height
of a subject’s offspring is strongly correlated with the
subject’s own height, but is unlikely to be substantially
inﬂuenced by the subject’s existing, but undiagnosed
illness. The latter assertion is untestable, but we argue that
it is plausible since (i) much of the variation in height is
genetically determined and (ii) most parental illness and
death occurs after children reach adult height. Thus, we
can use offspring height as an IV for own height, under the
assumption that this will better control for confounding by
existing illness, though we acknowledge that this approach
will not fully control for confounding by socioeconomic,
lifestyle or genetic characteristics which are shared by
parents and offspring. We have previously used this
approach to examine the causal effect of BMI on all-cause
and cause-speciﬁc mortality (Davey Smith et al., 2009).
2. Study population and data linkage
The unique national identity numbers and dates of birth
1980, and of their biological parents, were extracted from
the Swedish Multi-Generation Register (Fig. 1). The sons’
identity numbers were used to obtain their height, where
available, from records of conscription examinations
between September 1969 and December 2001. Weight
and blood pressure were also available from most
examinations, and smoking habits were available from
29,541 examinations, mostly in 1969 or 1970. Conscription
examinations were compulsory for young Swedish men
during the study period, except those with severe handicap
or chronic disease, and took place at a mean age of 18.3
years (range 16–25, with 91% aged 17 or 18). The 16% with
missing data were primarily due to accidental loss
following changes in data management at the conscription
authority. To avoid pseudo-replication within families,
only one son from each parent was retained in the data set.
Sons to be retained were randomly chosen, except that the
same son was retained for both of his parents whenever
possible.
Parents’ identity numbers were matched to the Swedish
Cause of Death Register, providing the underlying cause of
death for all deaths between 1961 and 2004. Emigration
records were also available, allowing the assumption that
parents not dead or emigrated by 31 December 2004 were
still alive at this time. The conscription examination
records included data for 71,836 father–son pairs, with
fathers having undergone examinations between 1969 and
1991. The Swedish Population and Housing Census
provided data on parents’ educational level and occupa-
tional socioeconomic index (SEI) in 1970 and 1990. We
took the higher of the 1970 and 1990 values for
educational level and classiﬁed it into ﬁve levels: <9
years; 9–10 years; full secondary; higher; and missing (2%
of mothers and 5% of fathers). We also classiﬁed parents
according to ﬁve mutually exclusive categories of occupa-
tional SEI: high/intermediate non-manual; low non-
manual; skilled manual; unskilled manual; and other/
missing. We used the 1970 value for parents born before
1935 and the 1990 value for parents born later. 27% of
mothers fell into the other/missing category, comprising
2% missing data and 25% others (including housewives,
farmers (<1%) and part-time workers). 20% of fathers were
categorised as other/missing, comprising 2% missing, 4%
farmers and 14% others. Cause-speciﬁc deaths (see Table
A1 in Appendix) were deﬁned using the international
classiﬁcation of diseases codes (ICD versions 7–10) from
the cause of death register, with some causes being subsets
of others (for example, site speciﬁc cancers were subsets of
cancer as a whole), in a similar manner to Davey Smith
et al. (2009).
Our ﬁnal main analyses were conducted on 997,110
father–son pairs and 1,013,293 mother–son pairs, with
additional analyses that used father’s height as well as
son’s height conducted on 71,836 father–son pairs (Fig. 1).
3. Statistical analysis
Son’s height was adjusted for secular trends and the
effect of age at examination by taking residuals from a
regression of son’s height on cubic splines of age at
examination and date of birth (7 knots at percentiles of 2.5,of all 1,629,396 boys born in Sweden between 1951 and
18.
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. A1 in Appendix). A similar adjustment was applied to
er’s height, where available. Within each quintile of
’s adjusted height, we summarised fathers’ health-
ted characteristics at conscription examination, par-
s’ education levels and ages at their son’s birth, and
s’ smoking (in a subset). Linear or logistic regression, as
ropriate and without further adjustment, was used to
mine the association of each of these variables with
’s height.
 Son’s height as a proxy for parental height in the whole
a set
Cox proportional hazards models were used to estimate
ard ratios (HR) for all-cause and cause-speciﬁc paternal
 maternal mortality per standard deviation (SD,
9 cm) of son’s height. Parental age was used as the
e axis, so all models were adjusted for this. Additional
ustment was also made for the occupational SEI and
cational level of the parent in question, which we will
r to collectively as socioeconomic position (SEP).
ervations were right-censored at the earliest of the
parent’s date of death or emigration, or on 31st December
2004 (the end of follow-up). They were left-censored at the
latest of the selected son’s date of birth or 1st January 1961
(the start of follow-up). Hazard ratios for maternal and
paternal mortality were compared by bootstrap resam-
pling of those sons with valid maternal and paternal
mortality (N = 973,440; 94% of those used for either
parent). Linearity of associations was tested using frac-
tional polynomials (Royston and Altman, 1994) of son’s
height in adjusted models. We also examined linearity of
associations visually by plotting HR by tenths of son’s
height.
3.2. Analysis of the subsample of data with the father’s own
height
Using the subsample of data for which the father’s own
height at conscription examination was available
(N = 71,836), the Cox proportional hazard models
described above for fathers’ all-cause and cause-speciﬁc
mortality were repeated. Using bootstrap resampling, HR
from these models were compared with those from models
using the same subsample, but using a father’s own height
1,629,396 sons born in Sweden between 195 1 and 198 0 and listed on the mu l-generaon register
1,837 mother-so n and 23,28 3 father-so n
pairs excluded because parent's death
occurred at or before son's birth.
264,784 mother-so n and 256,74 5 father-so n
pairs excluded because son’s height missing.
4 mother-son and 3 320 father-son pairs
11,554 mother-so n and 11,40 2 father-so n
pairs excluded because son’s date of
examina on or birth wa s missi ng or
   ,   
excluded because parent had death date bu t
no death cause, or vice-versa .
4 father-so n pairs excluded because father's
age exceeded Swedish ma le longevity record
(11 1 years and 12 8 day s).
implausible.
69 mother-so n and 21 0 father-so n pairs
excluded because parent died before the
follow-up period.
1,351,148 mother-so n pairs and 1,334,43 2 father-so n pairs (1,352,44 6 sons) with complete data
1 013 293 mother son pairs and 997 110 father son pairs (1 036 963 sons) with complete data and not
337,855 mother-so n and 337,32 2 father-so n
pairs excluded because parent already
represented in another pair.
, ,  -    ,  -   , ,       
repeated withi n famili es. Study populaon for summary stascs (Table 1) and mai n analyses (Tables 2 & 3)
924,100 father-so n pairs excluded because
father's height not available.1,174 father-so n pairs excluded because
father’s date of examina on or birth wa s
missing
71,836 father-so n pairs with complete data including father's height, and not repeated withi n famili es.
Study populaon for analys es requ iring father's height (Table 4)
ig. 1. Flow of participants through the study; parents of Swedish men born between 1951 and 1980 and subjected to conscription examination.
D. Carslake et al. / Economics and Human Biology 11 (2013) 351–359354in place of his son’s height. To make the outcomes of all
analyses comparable, HR were calculated per 6.49 cm (the
SD of son’s height) for both own height and son’s height.
3.3. Two-sample instrumental variables analysis
Two-sample IV analysis (Angrist and Krueger, 1992;
Didelez et al., 2010) allowed the estimation of HR for a
father’s all-cause and cause-speciﬁc mortality per 6.49 cm
of his own height. This approach makes maximum use of
the data available on fathers’ mortality (even when the
father’s height is not available, but his son’s is), and by
using son’s height as an instrument, estimates the effect of
own height on mortality in the absence of some sources of
confounding. First father’s height was regressed on son’s
height, adjusting for SEP, in the subset of data for which
both father’s and son’s height were available. We divided
the natural logarithm of the HR for mortality per SD of
son’s height (obtained by adjusted Cox models in the entire
data set, as described above) by the adjusted regression
coefﬁcient for father’s height against son’s height. This
ratio was exponentiated to give the two-sample IV hazard
ratio. Conﬁdence intervals were calculated using Taylor
series expansions (Thomas et al., 2007). All statistical
analyses were performed using Stata 11.2.
4. Results
There were 153,083 maternal deaths and 282,482
paternal deaths in the follow-up period. Table 1 shows
characteristics of sons and their parents by quintiles of
son’s height. Son’s height was strongly positively asso-
ciated with father’s height; the linear regression in Table 1
indicates that a father’s unadjusted height at conscription
examination increased by 3.04 cm (95% CI: 3.00, 3.08) for
every one SD (6.49 cm) increment in his son’s height
(adjusted). Taller sons were less likely to be smokers. Their
fathers were slightly older, with lower BMI and higher
systolic blood pressure, were less likely to smoke and more
likely to have completed more than 10 years of education.
Mothers of taller sons were also older and had completed
more education.
4.1. Association of son’s height with paternal and maternal
mortality
Tables 2 and 3 show the HRs for all-cause and cause-
speciﬁc parental mortality per one SD increase in son’s
height. Son’s height was inversely associated with all-
cause mortality in both mothers (adjusted HR 0.97, 95% CI:
0.96, 0.97) and fathers (adjusted HR 0.98, 95% CI: 0.98,
0.98). Parents of taller sons had lower mortality from CVD,
coronary heart disease (CHD), stroke, diabetes, respiratory
disease, external causes and suicide. The negative associa-
tions of son’s height with all-cause, CVD, CHD and
respiratory disease mortality were considerably stronger
for mothers than for fathers among sons with valid data on
both parents.
Parental death from cancer was positively associated
with son’s height in mothers (adjusted HR 1.02, 95% CI:
1.02, 1.03) and fathers (adjusted HR 1.02, 95% CI: 1.01,
1.03). This weak positive association was the result of a
mixture of positive and negative associations for speciﬁc
cancers. Smaller numbers of deaths for speciﬁc cancers led
to wide conﬁdence intervals, but there was evidence for a
negative association of son’s height with maternal lung
cancer, a positive association with paternal prostate
cancer, and a positive association with breast, colon and
kidney cancers in both parents. With the exception of lung
cancer (negative association for mothers and null for
fathers), HRs for cancer mortality did not differ between
mothers and fathers. Son’s height was also positively
associated with death from aortic aneurysm in fathers, but
not in mothers.
Associations generally attenuated slightly towards the
null with additional adjustment for SEP. The positive
associations with cancer (both parents) and aortic
aneurysm (fathers) provided exceptions to this, being
generally a little stronger after adjustment. Fractional
polynomial models found substantial evidence (P < 0.001)
Table 1
Characteristics of sons and parents according to quintiles of son’s height, adjusted for secular trends and age at examination. Linear and logistic regressions
of characteristics against son height are conducted per standard deviation (6.49 cm) of adjusted son’s height.
Subject Measurement Quintile of son’s height Regression coefﬁcient
or OR (95% CI)
N
1st 2nd 3rd 4th 5th
Sons Mean unadjusted heighta (cm) 170.3 175.8 179.2 182.7 188.4 1,036,963
Proportion smokersa (%) 64.0 60.1 59.3 58.4 54.1 0.87b (0.85, 0.90) 29,541
Fathers Mean unadjusted heighta (cm) 174.2 176.8 178.4 180.1 182.7 3.04 (3.00, 3.08) 73,010
Proportion smokersa (%) 66.2 64.2 64.2 63.5 59.7 0.91b (0.89, 0.94) 16,967
Mean age at son’s birth (years) 30.3 30.4 30.5 30.6 30.8 0.16 (0.15, 0.17) 997,110
Mean BMIa (kg m2) 21.3 21.3 21.3 21.2 21.2 0.04 (0.06, 0.02) 72,991
Mean systolic BPa (mm Hg) 126.4 126.6 126.8 126.7 127.3 0.32 (0.24, 0.40) 72,997
Proportion educated >10 years (%) 49.9 52.2 53.6 55.4 57.8 1.12b (1.12, 1.13) 949,032
Mothers Mean age at son’s birth (years) 27.0 27.2 27.4 27.5 27.8 0.26 (0.25, 0.27) 1,013,293
Proportion educated >10 years (%) 49.9 52.4 53.9 55.2 58.1 1.12b (1.12, 1.13) 994,098
Abbreviations: BMI: body mass index; BP: blood pressure; OR: odds ratio; CI: conﬁdence interval.
a Measured at time of conscription examination.
b Logistic regression; odds ratios (exponentiated coefﬁcients) are presented.
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se and CVD mortality with son’s height, and weaker
port (0.05 < P < 0.10) for CHD in mothers, and external
ses and suicide among fathers. Plots of mortality rates
inst tenths of son’s height (see Fig. A2 in Appendix)
gest that the statistical signiﬁcance owes more to the
siderable statistical power available than to the
gnitude of the nonlinearity, and that the linear
umption is not unreasonable in these analyses. The
ht nonlinearity of all-cause, CVD and CHD mortality in
tion to son’s height appeared to be due to the very
est sons, whose parents experienced higher mortality
s than would be expected from the overall negative
d (Fig. 2a–d). By contrast, the non-linearity in paternal
suicide and death from all external causes appeared to be
driven by particularly high mortality rates among the
fathers of the very shortest men.
4.2. Son’s height as an instrument for father’s height
The regression coefﬁcient used in the two-sample IV
analyses (with adjustment for SEP, and both heights
adjusted for their respective date of birth and age at
examination and scaled by a SD of 6.49 cm) was only
slightly lower than the unadjusted ﬁgure (Table 1), at
0.46 (95% CI: 0.45, 0.47); equivalent to 2.99 cm per SD
(95% CI: 2.95, 3.03). Two-sample IV estimates for
associations of a father’s own height with mortality
le 2
 models for maternal mortality per standard deviation (6.49 cm) of son’s height, adjusted for secular trends and age at examination.
use of death Deaths Age adjusted Age and SEP adjusted Comparison between
parentsa
Hazard ratio 95% CI Hazard ratio 95% CI
l cause 153,083 0.95 0.94, 0.95 0.97 0.96, 0.97 0.015
rdiovascular disease 50,922 0.91 0.91, 0.92 0.94 0.93, 0.95 <0.001
ronary heart disease 24,020 0.87 0.86, 0.88 0.90 0.88, 0.91 <0.001
rtic aneurysm 1529 1.01 0.96, 1.06 1.02 0.97, 1.07 0.085
roke 14,194 0.94 0.92, 0.95 0.96 0.94, 0.97 0.283
abetes 2603 0.82 0.79, 0.86 0.85 0.82, 0.89 0.037
spiratory diseases 7845 0.84 0.82, 0.86 0.86 0.84, 0.88 <0.001
ncer 62,307 1.01 1.00, 1.02 1.02 1.02, 1.03 0.907
ng cancer 7668 0.92 0.89, 0.94 0.92 0.90, 0.94 <0.001
east cancer 11,435 1.07 1.05, 1.09 1.08 1.06, 1.10 0.225
lon cancer 4751 1.03 1.00, 1.06 1.05 1.02, 1.08 0.291
omach cancer 2456 0.97 0.93, 1.01 1.00 0.96, 1.04 0.929
dney cancer 1983 1.01 0.96, 1.05 1.03 0.98, 1.07 0.492
ternal causes 9453 0.93 0.91, 0.95 0.95 0.93, 0.97 0.647
icide 3821 0.95 0.92, 0.98 0.97 0.94, 1.00 0.378
reviations: SEP: socioeconomic position (includes education and occupational socioeconomic index); CI: conﬁdence interval. N = 1,013,293 mothers at
 of mortality.
P-value for the comparison of age and SEP-adjusted hazard ratios between fathers (Table 3) and mothers. Calculated from 100 bootstrap resamples of
 with valid data on both parents.
le 3
ox models for paternal mortality per standard deviation (6.49 cm) of son’s height and (ii) adjusted two-sample IV models for paternal mortality against
 height, using son’s height as an instrument.
use of death Deaths Son’s height, age adjusted Son’s height, age and
SEP adjusted
Two-sample IV, age and SEP
adjusted
Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI
l cause 282,482 0.96 0.96, 0.97 0.98 0.98, 0.98 0.96 0.95, 0.96
rdiovascular disease 127,365 0.95 0.95, 0.96 0.97 0.96, 0.97 0.93 0.92, 0.95
ronary heart disease 81,776 0.94 0.93, 0.95 0.96 0.95, 0.97 0.91 0.90, 0.93
rtic aneurysm 5003 1.07 1.04, 1.10 1.07 1.04, 1.10 1.17 1.10, 1.24
roke 21,511 0.93 0.92, 0.94 0.95 0.93, 0.96 0.89 0.86, 0.91
abetes 4280 0.90 0.87, 0.93 0.92 0.89, 0.94 0.83 0.77, 0.88
spiratory diseases 14,021 0.93 0.91, 0.94 0.95 0.93, 0.96 0.88 0.85, 0.92
ncer 79,521 1.01 1.01, 1.02 1.02 1.01, 1.03 1.05 1.03, 1.06
ng cancer 15,053 0.97 0.96, 0.99 0.99 0.97, 1.01 0.98 0.94, 1.01
east cancer 70 1.29 1.02, 1.63 1.29 1.02, 1.63 1.74 1.04, 2.89
ostate cancer 12,714 1.02 1.00, 1.03 1.02 1.00, 1.03 1.04 1.00, 1.08
lon cancer 5779 1.02 0.99, 1.04 1.02 0.99, 1.04 1.04 0.98, 1.10
omach cancer 4930 0.98 0.95, 1.00 1.00 0.97, 1.03 1.00 0.94, 1.06
dney cancer 3513 1.05 1.01, 1.08 1.06 1.02, 1.09 1.13 1.05, 1.21
ternal causes 25,662 0.92 0.91, 0.93 0.95 0.94, 0.96 0.89 0.87, 0.91
icide 9569 0.93 0.91, 0.95 0.96 0.94, 0.98 0.91 0.87, 0.95
reviations: SEP: socioeconomic position (includes education and occupational socioeconomic index); IV, instrumental variables; CI: conﬁdence interval.97,110 fathers at risk of mortality and 71,836 father–son pairs with recorded height for the two-sample IV model. All heights were adjusted for secular
ds and age at examination.
D. Carslake et al. / Economics and Human Biology 11 (2013) 351–359356(Table 3) were further from the null than were the
corresponding Cox estimates, with wider conﬁdence
intervals. Nonetheless, they led to similar conclusions
for each cause of death.
Table 4 shows the association of all-cause and cause-
speciﬁc paternal mortality with son’s height and the
father’s own height within the subset of father–son pairs
for which the father’s height was available (Fig. 1), for
those causes with at least 50 deaths in the subset. The
associations of son’s height with fathers’ outcomes in this
subgroup were generally similar to those reported in Table
3 for the whole analysis cohort. For all outcomes except
lung cancer, the associations were stronger when the
although 95% conﬁdence intervals for the difference
between the two HR (from 100 bootstrap resamples)
invariably overlapped zero.
5. Discussion
In this study we used a son’s height as an IV to obtain
unbiased estimates of the associations between height and
mortality. The parents of taller sons had lower mortality
overall, and from CVD, CHD, stroke, diabetes, respiratory
disease, external causes and suicide. Son’s height was
positively associated in both parents with mortality from
cancer, and among fathers only, with mortality from aortic
Fig. 2. Hazard ratios (with 95% conﬁdence intervals) for mortality from (a and b) any cause, (c and d) cardiovascular disease and (e and f) external causes,
adjusted for age and socio-economic position, among the parents of Swedish men born between 1951 and 1980 and subjected to conscription examination.
The hazard ratio for each tenth of son’s height (adjusted for secular trends and age at examination) is plotted at its median value, with the ﬁrst tenth as the
reference group. Plots for all mortality causes, and by father’s own height, are available in Fig. A2 of Appendix.aneurysm.father’s own height, rather than his son’s, was used
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Our study beneﬁts from a very large, prospective
ple, comprising the parents of an almost complete
ulation cohort of young Swedish men. The only major
tion of the population excluded from our study is those
o do not have a son, or whose son does not survive to
scription age. The sample size gives us the statistical
er to investigate rarer causes of death, with greater
cision, than most previous studies. For example, the
ple size here is about twice that of a recent
aborative study combining mortality and own height
a from 113 prospective studies (Wormser et al., in
ss). The use of a son’s height rather than the parent’s
n height also contributed to the large sample size, since
 follow-up time required to record large numbers of
ths is reduced by the length of a generation.
Fathers who had had their own height recorded at
scription examination were a young, recent subsample,
resenting only 7% of the larger sample whose son’s
ght was measured. Causes of death affecting mainly
nger men, particularly external causes, dominate this
sample, making it difﬁcult to compare results with
se in the entire sample.
By using a son’s height as an instrument for parents’
ghts, we believe we have avoided confounding by
sting parental ill health as comprehensively as possible.
 rely on assumptions, and as is the case for all methods
ausal inference using observational data, some of these
 untestable (Didelez et al., 2010). An instrument should
strongly associated with the variable it replaces. Most
dies have found maternal and paternal height to be
ngly and similarly associated with offspring height
o et al., 1998; Pearson and Lee, 1903; Solomon et al.,
3), and we were able to conﬁrm this for paternal height
he present study population (we did not have data on
ternal height). An instrument should also be indepen-
t of the unmeasured confounding. A son’s height might
inﬂuenced by behavioural, genetic or socioeconomic
ors confounding mortality and height in the parent,
ough such associations may be weaker for the son’s
ght than for the parent’s own height. Finally, there must
be no pathway associating the outcome and the instru-
ment, except for those passing through the exposure. Apart
from the potential association between the instrument and
the confounders discussed above, it is difﬁcult to conceive
of other such pathways.
5.2. How do we interpret the results?
Son’s height is likely to be less inﬂuenced by the
potential confounding effect of adult ill health on both
height (usually shrinkage) and mortality. The similarity
between the results we obtained using (i) a father’s own
height, (ii) a son’s height, and (iii) a son’s height as an
instrument for his father’s height, suggest that confound-
ing by existing ill-health does not greatly inﬂuence the
associations between own height and mortality reported
here and elsewhere. The use of son’s height as an IV only
partially corrects for confounding by other factors, such as
socioeconomic position or genetic pleiotropy, because
these are strongly associated between parents and off-
spring. Such confounders remain possible drivers of our
observed associations between a son’s height and parental
mortality.
Our observation that son’s height is more strongly
predictive of maternal than paternal mortality may be due
to (i) stronger association between a son’s height and his
mother’s height, than his father’s height (e.g. due to a
greater degree of shared environment, or mis-assigned
paternity, although most studies (Luo et al., 1998; Pearson
and Lee, 1903; Solomon et al., 1983) ﬁnd that such
associations do not differ greatly between parents), (ii)
stronger unmeasured confounding of maternal than
paternal mortality with son’s height (e.g. through an
intra-uterine effect of maternal smoking) or (iii) a stronger
association between mortality and own height among
women than among men. The stronger prediction of
mothers’ mortality did not apply for the few outcomes we
tested which were positively associated with son’s height.
This would support the second of the three interpretations
above, although a more robust test of these alternatives
would require data on each mother’s own height. A recent
meta-analysis of 113 prospective studies (Wormser et al.,
le 4
ers’ mortality per standard deviation (6.49 cm) of height at conscription (son’s or own), adjusted for secular trends and age at examination.
use of death Deaths Son’s heighta, age
adjusted
Son’s heighta, age and
SEP adjusted
Own heighta, age
adjusted
Own heighta, age and
SEP adjusted
Hazard
ratio
95% CI Hazard
ratio
95% CI Hazard
ratio
95% CI Hazard
ratio
95% CI
l cause 2553 0.92 0.89, 0.96 0.95 0.92, 0.99 0.89 0.85, 0.92 0.93 0.89, 0.96
rdiovascular
disease
450 0.90 0.82, 0.98 0.92 0.84, 1.01 0.86 0.78, 0.95 0.90 0.82, 1.00
ronary heart
disease
248 0.88 0.78, 1.00 0.90 0.80, 1.03 0.77 0.68, 0.88 0.80 0.70, 0.92
roke 94 0.85 0.69, 1.04 0.87 0.71, 1.07 0.83 0.67, 1.03 0.87 0.70, 1.08
ncer 485 1.04 0.95, 1.14 1.06 0.97, 1.16 1.06 0.97, 1.17 1.08 0.98, 1.19
ng cancer 69 1.15 0.91, 1.46 1.17 0.93, 1.49 1.08 0.85, 1.38 1.12 0.87, 1.43
ternal causes 1147 0.89 0.84, 0.95 0.93 0.88, 0.99 0.86 0.81, 0.91 0.90 0.85, 0.96
icide 512 0.86 0.79, 0.94 0.90 0.82, 0.98 0.82 0.75, 0.90 0.86 0.79, 0.94
reviations: SEP: socioeconomic position (includes education and occupational socioeconomic index); CI: conﬁdence interval.
Separate analyses were made using either each father’s own height, or a son’s height. Data were restricted to father–son pairs where both heights were
lable (N = 71,836) and to death causes with at least 50 deaths.
D. Carslake et al. / Economics and Human Biology 11 (2013) 351–359358in press) found that the association of height with CHD in
women was somewhat stronger than the same association
in men, but noted no strong evidence of gender differences
for other outcomes.
Adjusting for SEP tended to increase the strength of
positive associations (i.e. aortic aneurysm, most cancers)
and attenuate the negative associations. This is probably
because parents of higher SEP have both lower mortality
rates and taller children due to healthier lifestyles. Data on
other potentially important confounders were very lim-
ited. It is likely, for example, that the negative association
between son’s height and maternal mortality from lung
cancer (Table 2) is largely due to confounding by smoking,
with lower levels of smoking among the mothers of taller
sons. However, we do not have information on smoking
among mothers to test this.
The relationships we observed between cause-speciﬁc
mortality rates and son’s height were close to linear on the
logarithmic scale assumed by Cox regression (see Fig. A2 in
Appendix). Deviations from this linear trend suggested a
detrimental effect on survival of being extremely tall or
short, beyond the trend seen in the population as a whole.
Some studies (Engeland et al., 2003; Koch, 2011) have
suggested that the association between height and all-
cause mortality may be positive among the very tallest
women, but not men. Within the tallest tenth of sons, we
found that all-cause mortality in both parents was
unrelated, or perhaps slightly positively associated, with
son’s height, although there was no indication of this
among the limited data available for fathers’ own height
(see Fig. A3 in Appendix).
5.3. Comparison with other studies
To the best of our knowledge, this is the ﬁrst study to
use son’s height as an instrument for parents’ height.
Previous studies, including the very large emerging risk
factor collaboration of over a million individuals (Wormser
et al., in press) have found inverse associations between a
subject’s own height and their mortality from all causes
(Engeland et al., 2003; Jousilahti et al., 2000; Song and
Sung, 2008), CVD (Cook et al., 1994; Lee et al., 2009;
Paajanen et al., 2010) and external causes (Koch, 2011; Lee
et al., 2009; Song and Sung, 2008), and positive associa-
tions with mortality from most cancers (Batty et al., 2010;
Green et al., 2011; Gunnell et al., 2001). Our ﬁndings, using
son’s height as an instrumental variable, are consistent
with these results.
6. Conclusions
We found that height at age 18 was inversely
associated with mortality from all-causes, CVD, CHD,
stroke, diabetes, respiratory disease, external causes and
suicide. It was positively associated with mortality from
cancer and, in fathers, from aortic aneurysm. Using son’s
height as an instrumental variable for parent’s height
allowed us to explore whether conventional approaches
to examining the association of height with mortality are
biased by ill-health resulting in shrinkage. The associa-
were similar whether an instrumental variables approach
or a conventional multivariable approach was used. This
suggests that shrinkage due to ill-health was not an
important source of confounding, and increases the
conﬁdence with which we can interpret conventional
analyses of mortality–height associations, at least when
height has been measured in young adulthood. Our
approach may also have reduced the effect of other
unmeasured confounding, but the extent of this is difﬁcult
to judge. Further studies are required to examine the
extent to which other sources of confounding may explain
these results and the likelihood of other (biological)
mechanisms for these associations.
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